---
title: hema.to
date: 2023-06-26T13:53:50Z
modified: 2026-08-11T10:28:48Z
permalink: "https://www.htgf.de/en/portfolio/htgffamily/hema-to/"
type: portfolio
status: publish
excerpt: ""
wpid: 107952
language:
  - English
post_translations:
  - pll_649987528cb42
branchen22:
  - Diagnostic
sectors:
  - Diagnostics & R&D Tools
  - Digital Health
focus_areas:
  - Diagnostics
  - R&D Tools
timestamp: 2026-08-11T10:28:48Z
tags:
  - English
  - pll_649987528cb42
  - Diagnostic
  - Diagnostics & R&D Tools
  - Digital Health
  - Diagnostics
  - R&D Tools
---

## Beschreibungstext

hema.to is an easy-to-use software for clinical decision support for blood cancer from cytometry data using AI. hema.to makes the diagnostic workflow both faster and better, helping both diagnosticians as well as patients. hema.to is a CE-IVD, FDA registered and already in routine use by leading hematology laboratories. Founded in 2021, hema.to’s mission is to make clinical analysis of cytometry data completely objective, to enable doctors to personalize treatment to their patient’s unique immune system.

## Unternehmenswebsite

http://hema.to/

## Adresse

hema.to GmbH
Ainmillerstr. 22
80801 Munich

## Kontakt

Array